Responders had a lower expression of the miRisk miRNAs, which may reflect reactivation of the PD1/PD-L1 signaling pathway in peripheral immune cells, and this reactivation status may be maintained upon migration of the peripheral immune cells into the tumor microenvironment. Here, CD274 is linked to neoplasm.